<--- Back to Details
First PageDocument Content
Applied genetics / Biotechnology / RNA / Myotonic dystrophy / Antisense therapy / Molecular biology / Sense / DM1 / Muscular dystrophy / Biology / Genetics / Health
Date: 2014-06-11 11:20:11
Applied genetics
Biotechnology
RNA
Myotonic dystrophy
Antisense therapy
Molecular biology
Sense
DM1
Muscular dystrophy
Biology
Genetics
Health

060514_DMPK_FactSheet_Graphic

Add to Reading List

Source URL: mda_assets.s3.amazonaws.com

Download Document from Source Website

File Size: 176,68 KB

Share Document on Facebook

Similar Documents

Large ElectronPositron Collider

Biotechnology, BS "DBEFNJD.BQ  5IF"DBEFNJD.BQTFSWFTBTBTVHHFTUFEDPVSTFTFRVFODFPOMZ4UVEFOUTBSFOPUMJNJUFEUPUIJTQMBOJUJTNFBOUUPCFVTFEBT

DocID: 1xTqy - View Document

PDF Document

DocID: 1wroO - View Document

Building A Better Mousetrap: Patenting Biotechnology In The European Community

DocID: 1vr7C - View Document

BIOTECH & PHARMA IN FRANCE KEY FACTS & FIGURES ¾¾ The French biotechnology sector ranks number 3 in Europe with more than 400 companies behind the UK and Germany ¾¾ First producer of medicines in Europe with 220 prod

DocID: 1vq6b - View Document

Biotechnology Consultation Agency Response Letter BNF

DocID: 1vpUZ - View Document